FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2391434619> ?p ?o ?g. }

• W2391434619 abstract "Antipsychotic agents, utilized for the treatment of a range of psychiatric disorders, differ substantially in terms of their pharmacology and adverse effect profiles. Incomplete and variable efficacy, differences in safety-tolerability, and highly heterogeneous response across individuals prompt development of new agents. Brexpiprazole is one of the two most recently introduced antipsychotic agents approved for the treatment of schizophrenia and as an adjunct for treatment of major depressive disorder. Its pharmacology, clinical trial data, and efficacy and side effects in comparison with other antipsychotic agents are discussed. Brexpiprazole is a dopamine D-2 partial agonist with potent activity at the serotonin 5HT1A and 5HT2A and noradrenergic alpha-1B and alpha-2C receptors. Placebo-controlled clinical trials in persons with schizophrenia support its efficacy in treating psychosis and preventing relapse. Short-term clinical trials also support its efficacy as an adjunct to antidepressants in treating major depressive disorder in individuals inadequately responsive to antidepressant treatment alone. Adverse effects include akathisia, gastrointestinal side effects, and moderate weight gain. The recommended oral dose of brexpiprazole is 2-4 mg/day in schizophrenia and 2-3 mg/day as adjunctive treatment in major depression. It must be titrated up to its target dose over 1-2 weeks and is effective in once-daily dosing. How brexpiprazole's unique pharmacological profile will translate into clinically meaningful differences from other antipsychotic agents is unclear. Its place in our antipsychotic armamentarium and potential role in the treatment of schizophrenia and major depressive disorder will be determined by additional clinical data and experience." @default.
• W2391434619 created "2016-06-24" @default.
• W2391434619 creator A5035380756 @default.
• W2391434619 creator A5042331957 @default.
• W2391434619 date "2016-05-01" @default.
• W2391434619 modified "2023-10-18" @default.
• W2391434619 title "Spotlight on brexpiprazole and its potential in the treatment of schizophrenia and as adjunctive therapy for the treatment of major depression" @default.
• W2391434619 cites W177607866 @default.
• W2391434619 cites W1868790909 @default.
• W2391434619 cites W1977070136 @default.
• W2391434619 cites W1990121386 @default.
• W2391434619 cites W2006080570 @default.
• W2391434619 cites W2007880575 @default.
• W2391434619 cites W2020136635 @default.
• W2391434619 cites W2020739757 @default.
• W2391434619 cites W2027949421 @default.
• W2391434619 cites W2064065127 @default.
• W2391434619 cites W2069849124 @default.
• W2391434619 cites W2078154303 @default.
• W2391434619 cites W2081141967 @default.
• W2391434619 cites W2120893202 @default.
• W2391434619 cites W2131823335 @default.
• W2391434619 cites W2139078690 @default.
• W2391434619 cites W2140725933 @default.
• W2391434619 cites W2151839057 @default.
• W2391434619 cites W2152358682 @default.
• W2391434619 cites W2154299176 @default.
• W2391434619 cites W2274260754 @default.
• W2391434619 doi "https://doi.org/10.2147/dddt.s85089" @default.
• W2391434619 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4869657" @default.
• W2391434619 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27274197" @default.
• W2391434619 hasPublicationYear "2016" @default.
• W2391434619 type Work @default.
• W2391434619 sameAs 2391434619 @default.
• W2391434619 citedByCount "3" @default.
• W2391434619 countsByYear W23914346192018 @default.
• W2391434619 countsByYear W23914346192019 @default.
• W2391434619 countsByYear W23914346192020 @default.
• W2391434619 crossrefType "journal-article" @default.
• W2391434619 hasAuthorship W2391434619A5035380756 @default.
• W2391434619 hasAuthorship W2391434619A5042331957 @default.
• W2391434619 hasBestOaLocation W23914346191 @default.
• W2391434619 hasConcept C118552586 @default.
• W2391434619 hasConcept C126322002 @default.
• W2391434619 hasConcept C126855140 @default.
• W2391434619 hasConcept C15744967 @default.
• W2391434619 hasConcept C170493617 @default.
• W2391434619 hasConcept C197934379 @default.
• W2391434619 hasConcept C2775864247 @default.
• W2391434619 hasConcept C2776412080 @default.
• W2391434619 hasConcept C2776921671 @default.
• W2391434619 hasConcept C2777393122 @default.
• W2391434619 hasConcept C2778375690 @default.
• W2391434619 hasConcept C2778938600 @default.
• W2391434619 hasConcept C2779727114 @default.
• W2391434619 hasConcept C2780051608 @default.
• W2391434619 hasConcept C2780494398 @default.
• W2391434619 hasConcept C2780733359 @default.
• W2391434619 hasConcept C3018162438 @default.
• W2391434619 hasConcept C53910766 @default.
• W2391434619 hasConcept C58732023 @default.
• W2391434619 hasConcept C71924100 @default.
• W2391434619 hasConcept C98274493 @default.
• W2391434619 hasConceptScore W2391434619C118552586 @default.
• W2391434619 hasConceptScore W2391434619C126322002 @default.
• W2391434619 hasConceptScore W2391434619C126855140 @default.
• W2391434619 hasConceptScore W2391434619C15744967 @default.
• W2391434619 hasConceptScore W2391434619C170493617 @default.
• W2391434619 hasConceptScore W2391434619C197934379 @default.
• W2391434619 hasConceptScore W2391434619C2775864247 @default.
• W2391434619 hasConceptScore W2391434619C2776412080 @default.
• W2391434619 hasConceptScore W2391434619C2776921671 @default.
• W2391434619 hasConceptScore W2391434619C2777393122 @default.
• W2391434619 hasConceptScore W2391434619C2778375690 @default.
• W2391434619 hasConceptScore W2391434619C2778938600 @default.
• W2391434619 hasConceptScore W2391434619C2779727114 @default.
• W2391434619 hasConceptScore W2391434619C2780051608 @default.
• W2391434619 hasConceptScore W2391434619C2780494398 @default.
• W2391434619 hasConceptScore W2391434619C2780733359 @default.
• W2391434619 hasConceptScore W2391434619C3018162438 @default.
• W2391434619 hasConceptScore W2391434619C53910766 @default.
• W2391434619 hasConceptScore W2391434619C58732023 @default.
• W2391434619 hasConceptScore W2391434619C71924100 @default.
• W2391434619 hasConceptScore W2391434619C98274493 @default.
• W2391434619 hasLocation W23914346191 @default.
• W2391434619 hasLocation W23914346192 @default.
• W2391434619 hasLocation W23914346193 @default.
• W2391434619 hasLocation W23914346194 @default.
• W2391434619 hasOpenAccess W2391434619 @default.
• W2391434619 hasPrimaryLocation W23914346191 @default.
• W2391434619 hasRelatedWork W1969572806 @default.
• W2391434619 hasRelatedWork W2033155032 @default.
• W2391434619 hasRelatedWork W2042056993 @default.
• W2391434619 hasRelatedWork W2069869805 @default.
• W2391434619 hasRelatedWork W2167059050 @default.
• W2391434619 hasRelatedWork W2276969057 @default.
• W2391434619 hasRelatedWork W2345647650 @default.
• W2391434619 hasRelatedWork W2391434619 @default.
• W2391434619 hasRelatedWork W2541364372 @default.
• W2391434619 hasRelatedWork W2905349616 @default.

• next